Atomo Diagnostics Limited (AT1.AX)
AUD 0.02
(-5.0%)
AUD 0.02
(-5.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 84.67 Thousand AUD | -66.78% |
| 2023 | 254.87 Thousand AUD | -25.21% |
| 2022 | 340.8 Thousand AUD | 404.23% |
| 2021 | 67.58 Thousand AUD | 21.69% |
| 2020 | 55.54 Thousand AUD | -99.46% |
| 2019 | 10.33 Million AUD | -10.01% |
| 2018 | 11.48 Million AUD | 4.79% |
| 2017 | 10.96 Million AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 171.46 Thousand AUD | -32.73% |
| 2024 FY | 84.67 Thousand AUD | -66.78% |
| 2024 Q4 | 84.67 Thousand AUD | -50.62% |
| 2023 Q2 | 271.71 Thousand AUD | -20.27% |
| 2023 Q4 | 254.87 Thousand AUD | -6.2% |
| 2023 FY | 254.87 Thousand AUD | -25.21% |
| 2022 Q4 | 340.8 Thousand AUD | -19.06% |
| 2022 FY | 340.8 Thousand AUD | 404.23% |
| 2022 Q2 | 421.05 Thousand AUD | 522.96% |
| 2021 Q4 | 67.58 Thousand AUD | 12.69% |
| 2021 Q2 | 59.97 Thousand AUD | 7.99% |
| 2021 FY | 67.58 Thousand AUD | 21.69% |
| 2020 FY | 55.54 Thousand AUD | -99.46% |
| 2020 Q4 | 55.54 Thousand AUD | -99.77% |
| 2020 Q2 | 23.98 Million AUD | 132.01% |
| 2019 Q4 | 10.33 Million AUD | 0.0% |
| 2019 FY | 10.33 Million AUD | -10.01% |
| 2018 FY | 11.48 Million AUD | 4.79% |
| 2017 FY | 10.96 Million AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 98.346% |
| Adherium Limited | 93.2 Thousand AUD | 9.157% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 98.758% |
| Anteris Technologies Ltd | 2.33 Million AUD | 96.371% |
| Control Bionics Limited | 961.73 Thousand AUD | 91.196% |
| CardieX Limited | 3.22 Million AUD | 97.377% |
| Compumedics Limited | 6.97 Million AUD | 98.786% |
| Cochlear Limited | 243.7 Million AUD | 99.965% |
| CleanSpace Holdings Limited | 3.44 Million AUD | 97.543% |
| Cyclopharm Limited | 4.22 Million AUD | 97.997% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | 97.081% |
| Nova Eye Medical Limited | 3.34 Million AUD | 97.472% |
| HeraMED Limited | 260.65 Thousand AUD | 67.517% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 99.461% |
| ImpediMed Limited | 1.14 Million AUD | 92.592% |
| InhaleRx Limited | 560.27 Thousand AUD | 84.888% |
| LBT Innovations Limited | 1.74 Million AUD | 95.142% |
| Micro-X Limited | 4.05 Million AUD | 97.912% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -19.807% |
| PolyNovo Limited | 15.38 Million AUD | 99.449% |
| Respiri Limited | 1.17 Million AUD | 92.804% |
| SomnoMed Limited | 1.01 Million AUD | 91.666% |
| Universal Biosensors, Inc. | 4.97 Million AUD | 98.297% |
| Uscom Limited | 989.27 Thousand AUD | 91.441% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | 72.876% |